Biotech News
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
ir.pliantrx.com2026-05-06 14:53 EST
BEACON-IPF close out activities continue Previously announced workforce and operational realignment largely complete Phase 1 oncology trial on track to deliver additional data by the end of the year SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc.